ENDAVA (NYSE: DAVA) Replaces CEO and CFO, Confirms Financial Statements Are Unreliable, Contracts Lack Economic Substance, Financial Restatements Pending - Hagens Berman
Stock Information for Anavex Life Sciences Corp.
Loading
Please wait while we load your information from QuoteMedia.